FDA awards full approval to Paxlovid amidst hazy coverage plans
A person holds packets of the antiviral drug Paxlovid. Image Credit: Getty Images/ Chris Sweda/Chicago Tribune/Tribune News Service After earning
Read MoreA person holds packets of the antiviral drug Paxlovid. Image Credit: Getty Images/ Chris Sweda/Chicago Tribune/Tribune News Service After earning
Read MorePharma company merger and acquisition (M&A) activity in the first half of 2023 has remained relatively low, consistent with the
Read MoreUK chancellor Jeremy Hunt has told drugmakers that the government has no “magic wand” to deal with financial pressures and
Read MoreThe 2023 Emerging Pharma Leaders share with the Pharmaceutical Executive editors what makes a good leader, what has made them
Read MoreZentalis Pharmaceuticals: A Promising Investment Opportunity In a day and age where the pharmaceutical industry is booming, it’s difficult to
Read MoreMarket Overview Published Via 11Press : Global Generative AI in Pharma market size is expected to be worth around USD 2258.1
Read MoreIntroduction to Generative AI Artificial Intelligence (AI) is a fast-evolving technology that has been changing various industries in recent years.
Read MoreThis photo provided by Indivior in May 2023 shows their drug Opvee. U.S. health regulators approved the medication to reverse
Read MoreThe Pfizer business model is centered around discovering, developing, manufacturing, marketing, selling, and distributing biopharmaceutical products around the world. It
Read MoreFTC sues Amgen-Horizon, raising questions about PBM role in drug costsFor You U.S. Sports Entertainment Life Money Tech Travel Opinion
Read More